SCHEMBL322087

SCHEMBL322087

NC(=O)CC1(O)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14795224 0.95 CYP2C19 (0.44)
SCHEMBL4770611 0.92 CYP2C19 (0.47)
SCHEMBL1968142 0.78 KDM4E (0.43)
SCHEMBL10280046 0.77 L3MBTL1 (0.33)
SCHEMBL322137 0.76
SCHEMBL20520325 0.75 L3MBTL1 (0.35)
SCHEMBL17446962 0.74
SCHEMBL15774512 0.74
SCHEMBL23277774 0.72 GRIN2D (0.38)
SCHEMBL10232783 0.72 CYP2D6 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590984-A1 ANELLATED PYRIDINE COMPOUNDS F.HOFFMANN-LA ROCHE AG (CH) 2013-05-15 EP claimed
WO-2012004206-A1 ANELLATED PYRIDINE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 WO claimed
WO-2011161009-A1 ANELLATED PYRIDINE COMPOUNDS AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-29 WO claimed